Blogging in 2026 is a professional pursuit that blends the timeless principles of valuable writing and audience trust with ...
The biggest stories of the day delivered to your inbox.
Pharvaris, a late-stage biopharmaceutical company focused on developing oral bradykinin B2 receptor antagonists for bradykinin-mediated diseases like hereditary angioedema (HAE), has updated the ...
The moon is looking bright in the sky tonight, and that's for good reason. It's all down to where we are in the current lunar cycle. What is the lunar cycle, you ask? This is a recurring series of ...
Institute of Molecular Biotechnology, Graz University of Technology, Petersgasse 14, Graz 8010 Austria School of Biology and Biological Engineering, South China University of Technology, Guangzhou ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and ...
EdSource · The John Fensterwald forecast: What’s coming for California schools in 2026 The John Fensterwald forecast: What’s coming for California schools in 2026 January 8, 2026 - It's time for John ...
GameSpot may get a commission from retail offers. The Nintendo Switch 2 is reportedly launching in June, with a three-phase plan for rolling out both first- and third-party games throughout the rest ...
A phase 3 trial of Immunovant’s FcRn inhibitor batoclimab has hit its primary endpoint. But, having made a second-generation molecule its lead candidate last year, the biotech isn’t currently planning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback